Mary Van Helden
Director Byondis
Seminars
Tuesday 4th November 2025
Introducing Phosphonate-ADCs: a Novel Immunostimulatory ADC Class Driving Inside-Out Activation of Vγ9Vδ2 T Cells to Selectively Kill Tumor Cells
12:00 pm
- Exploring immunostimulatory ADCs that redirect Vγ9Vδ2 T-cells to selectively target and kill tumor cells
- Spotlighting MHC-independent MoA, providing a promising solution to overcome resistance to approved CPIs
- Combining linker-drug platform with any targeted moiety, offering potential applications beyond immuno-oncology
